Search Results - "TRERE, D"

Refine Results
  1. 1

    basal-like breast carcinoma phenotype is regulated by SLUG gene expression by Storci, G, Sansone, P, Trere, D, Tavolari, S, Taffurelli, M, Ceccarelli, C, Guarnieri, T, Paterini, P, Pariali, M, Montanaro, L, Santini, D, Chieco, P, Bonafé, M

    Published in The Journal of pathology (01-01-2008)
    “…Basal-like breast carcinoma is an aggressive form of breast cancer, characterized by the absence of oestrogen receptor and HER2 expression, the presence of…”
    Get full text
    Journal Article
  2. 2

    Interleukin 6 downregulates p53 expression and activity by stimulating ribosome biogenesis: a new pathway connecting inflammation to cancer by Brighenti, E, Calabrese, C, Liguori, G, Giannone, F A, Trerè, D, Montanaro, L, Derenzini, M

    Published in Oncogene (28-08-2014)
    “…Chronic inflammation is an established risk factor for the onset of cancer, and the inflammatory cytokine IL-6 has a role in tumorigenesis by enhancing…”
    Get full text
    Journal Article
  3. 3

    Direct relationship between the level of p53 stabilization induced by rRNA synthesis-inhibiting drugs and the cell ribosome biogenesis rate by Scala, F, Brighenti, E, Govoni, M, Imbrogno, E, Fornari, F, Treré, D, Montanaro, L, Derenzini, M

    Published in Oncogene (25-02-2016)
    “…Many drugs currently used in chemotherapy work by hindering the process of ribosome biogenesis. In tumors with functional p53, the inhibition of ribosome…”
    Get full text
    Journal Article
  4. 4

    The balance between rRNA and ribosomal protein synthesis up- and downregulates the tumour suppressor p53 in mammalian cells by Donati, G, Bertoni, S, Brighenti, E, Vici, M, Treré, D, Volarevic, S, Montanaro, L, Derenzini, M

    Published in Oncogene (21-07-2011)
    “…Data on the relationship between ribosome biogenesis and p53 function indicate that the tumour suppressor can be activated by either nucleolar disruption or…”
    Get full text
    Journal Article
  5. 5

    High prevalence of retinoblastoma protein loss in triple-negative breast cancers and its association with a good prognosis in patients treated with adjuvant chemotherapy by Treré, D., Brighenti, E., Donati, G., Ceccarelli, C., Santini, D., Taffurelli, M., Montanaro, L., Derenzini, M.

    Published in Annals of oncology (01-11-2009)
    “…Background: Triple-negative breast cancer (TNBC) is an aggressive disease, nevertheless exhibiting a high response rate to chemotherapy. Since the…”
    Get full text
    Journal Article
  6. 6

    AgNOR staining and quantification by Trerè, D

    Published in Micron (Oxford, England : 1993) (01-04-2000)
    “…Nucleolar organiser regions (NORs) are defined as nucleolar components containing a set of argyrophilic proteins, which are selectively stained by silver…”
    Get full text
    Journal Article
  7. 7

    Dyskerin expression influences the level of ribosomal RNA pseudo-uridylation and telomerase RNA component in human breast cancer by Montanaro, L, Brigotti, M, Clohessy, J, Barbieri, S, Ceccarelli, C, Santini, D, Taffurelli, M, Calienni, M, Teruya-Feldstein, J, Trerè, D, Pandolfi, PP, Derenzini, M

    Published in The Journal of pathology (01-09-2006)
    “…Dyskerin is a nucleolar protein, altered in dyskeratosis congenita, which carries out two separate functions, both fundamental for proliferating cells. One…”
    Get full text
    Journal Article
  8. 8

    Nucleolus, Ribosomes, and Cancer by Montanaro, Lorenzo, Treré, Davide, Derenzini, Massimo

    Published in The American journal of pathology (01-08-2008)
    “…The complex aspects linking the nucleolus and ribosome biogenesis to cancer are reviewed here. The available evidence indicates that the morphological and…”
    Get full text
    Journal Article
  9. 9

    c‐erbB‐2 over‐expression in amplified and non‐amplified breast carcinoma samples by Farabegoli, Fulvia, Ceccarelli, Claudio, Santini, Donatella, Baldini, Nicola, Taffurelli, Mario, Marrano, Domenico, Treré, Davide, Derenzini, Massimo

    Published in International journal of cancer (21-06-1999)
    “…We investigated c‐erbB‐2 oncogene amplification and over‐expression in 79 invasive breast carcinoma samples using fluorescence in situ hybridization (FISH) and…”
    Get full text
    Journal Article
  10. 10

    Prognostic relevance of a novel semiquantitative classification of Bcl2 immunohistochemical expression in human infiltrating ductal carcinomas of the breast by Treré, D, Montanaro, L, Ceccarelli, C, Barbieri, S, Cavrini, G, Santini, D, Taffurelli, M, Derenzini, M

    Published in Annals of oncology (01-06-2007)
    “…Background: Bcl2 is an important prognostic parameter in human breast cancer. However, the evaluation of Bcl2 expression by immunohistochemistry is carried out…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Different effects of ribosome biogenesis inhibition on cell proliferation in retinoblastoma protein- and p53-deficient and proficient human osteosarcoma cell lines by Montanaro, L., Mazzini, G., Barbieri, S., Vici, M., Nardi-Pantoli, A., Govoni, M., Donati, G., Treré, D., Derenzini, M.

    Published in Cell proliferation (01-08-2007)
    “…  Objectives: To evaluate the effects of rRNA synthesis inhibition on cell cycle progression and cell population growth according to the RB and p53 status…”
    Get full text
    Journal Article
  13. 13

    Nucleolar size indicates the rapidity of cell proliferation in cancer tissues by Derenzini, Massimo, Trerè, Davide, Pession, Annalisa, Govoni, Marzia, Sirri, Valentina, Chieco, Pasquale

    Published in The Journal of pathology (01-06-2000)
    “…In order to define the importance of the nucleolus in tumour pathology, the relationship between nucleolar size and function and tumour mass growth rate was…”
    Get full text
    Journal Article
  14. 14

    The prognostic value of the AgNOR parameter in human breast cancer depends on the pRb and p53 status by Derenzini, M, Ceccarelli, C, Santini, D, Taffurelli, M, Treré, D

    Published in Journal of clinical pathology (01-07-2004)
    “…Background: The amount of argyrophilic nucleolar organiser regions (AgNORs) represents a cell kinetics parameter used in tumour pathology for prognostic…”
    Get full text
    Journal Article
  15. 15

    Hyperoxia fully protects mitochondria of explanted livers by Sgarbi, G., Giannone, F., Casalena, G. A., Baracca, A., Baldassare, M., Longobardi, P., Caraceni, P., Derenzini, M., Lenaz, G., Trerè, D., Solaini, Giancarlo

    Published in Journal of bioenergetics and biomembranes (01-12-2011)
    “…Liver ischemia-reperfusion injury is still an open problem in many clinical circumstances, including surgery and transplantation. This study investigates how…”
    Get full text
    Journal Article
  16. 16

    Nucleolar function and size in cancer cells by Derenzini, M, Trere, D, Pession, A, Montanaro, L, Sirri, V, Ochs, RL

    Published in The American journal of pathology (01-05-1998)
    “…We have have studied the relationship between nucleolar function and size and cell doubling time in cancer cells. Seven human cancer cell lines characterized…”
    Get full text
    Journal Article
  17. 17

    The quantity of nucleolar proteins nucleolin and protein B23 is related to cell doubling time in human cancer cells by Derenzini, M, Sirri, V, Trerè, D, Ochs, R L

    Published in Laboratory investigation (01-10-1995)
    “…The quantity of the silver-stained nucleolar proteins (AgNOR proteins) measured in situ in cytohistologic preparations is related to the rapidity of cell…”
    Get more information
    Journal Article
  18. 18

    Qualitative and quantitative analysis of AgNOR proteins in chemically induced rat liver carcinogenesis by Trere, D, Derenzini, M, Sirri, V, Montanaro, L, Grigioni, W, Faa, G, Columbano, GM, Columbano, A

    Published in Hepatology (Baltimore, Md.) (01-11-1996)
    “…A qualitative and quantitative analysis of silver-stained nuclear organizer regions (AgNOR) proteins was performed during hepatocarcinogenesis induced in rats…”
    Get full text
    Journal Article
  19. 19

    The asialoglycoprotein receptor in human hepatocellular carcinomas: its expression on proliferating cells by TRERE, D, FIUME, L, BADIALI DE GIORGI, L, DI STEFANO, G, MIGALDI, M, DERENZINI, M

    Published in British Journal of Cancer (01-10-1999)
    “…The expression of the asialoglycoprotein receptor (ASGP-R) on human hepatocellular carcinoma (HCC) cells might be exploited to reduce the extrahepatic toxicity…”
    Get full text
    Journal Article
  20. 20

    Correlation between the Histopathological Diagnosis by AgNOR Count and AgNOR Area in Canine Mammary Tumors by Bundgaard-Andersen, K, Flagstad, A, Jensen, A.L, Hellmen, E, Trere, D

    Published in Journal of veterinary internal medicine (01-09-2008)
    “…Background: Mammary tumors are the most common type of tumor in female dogs. The histopathological diagnosis is usually made by a hematoxylin‐eosin (HE)…”
    Get full text
    Journal Article